SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-010193
Filing Date
2018-08-01
Accepted
2018-08-01 16:06:37
Documents
85
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akorn10q-06302018.htm 10-Q 1263084
2 EXHIBIT 31.1 exhibit311-06302018.htm EX-31.1 13548
3 EXHIBIT 31.2 exhibit312-06302018.htm EX-31.2 13556
4 EXHIBIT 32.1 exhibit321-06302018.htm EX-32.1 8783
5 EXHIBIT 32.2 exhibit322-06302018.htm EX-32.2 8799
  Complete submission text file 0001628280-18-010193.txt   7830321

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20180630.xml EX-101.INS 1845761
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20180630.xsd EX-101.SCH 57275
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20180630_cal.xml EX-101.CAL 91592
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20180630_def.xml EX-101.DEF 234865
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20180630_lab.xml EX-101.LAB 736470
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20180630_pre.xml EX-101.PRE 438905
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 18984789
SIC: 2834 Pharmaceutical Preparations